Prostate Cancer, Part 2: PSMA and Beyond
Journal of Nuclear Medicine Technology · 2026-06 · 54 (2) · 136-143
DOI: 10.2967/jnmt.125.271979 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine Technology, online erschienen am 28.04.2026. Verfasst von Geoffrey M Currie und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia; and gcurrie@csu.edu.au. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Antigens, Surface, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia; and gcurrie@csu.edu.au.
- School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia; and.
- Paul L. Foster School of Medicine, Texas Tech University Health Center, El Paso, Texas.
Zitieren
APA
Currie, G. M., & Rohren, E. M. (2026). Prostate Cancer, Part 2: PSMA and Beyond. Journal of Nuclear Medicine Technology, 54(2), 136-143. https://doi.org/10.2967/jnmt.125.271979
Vancouver
Currie GM, Rohren EM. Prostate Cancer, Part 2: PSMA and Beyond. Journal of Nuclear Medicine Technology. 2026;54(2):136-143. doi:10.2967/jnmt.125.271979
BibTeX
@article{Currie2026,
author = {Currie, Geoffrey M and Rohren, Eric M},
title = {Prostate Cancer, Part 2: PSMA and Beyond},
journal = {Journal of Nuclear Medicine Technology},
year = {2026},
volume = {54},
number = {2},
pages = {136--143},
doi = {10.2967/jnmt.125.271979}
}
EUVIMED